SeaStar Medical ICU Investor Presentation September 2024

Loading viewer...

investor_presentation

Format: PDF investor_presentation

SeaStar Medical is a commercial-stage medical device company developing the Selective Cytopheretic Device (SCD), an extracorporeal platform designed to treat life-threatening hyperinflammation in critically ill patients. The technology targets cytokine storms and aims to restore organ function across multiple therapeutic applications.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from SeaStar Medical

View all →

presentation

SeaStar Medical Hyperinflammation Therapy 2023 Investor Presentation

investor_presentation

Similar investor_presentations from other companies

Browse all →

Teva Pharmaceutical Industries Investor Presentation — November 2020

investor_presentation

36 Pages

Teva Pharmaceutical Industries

Banca Generali 1H 2024 Results Investor Presentation

investor_presentation